ACADIA Pharmaceuticals Overview

  • Founded
  • 1993
Founded
  • Status
  • Public
  • Employees
  • 580
Employees
  • Stock Symbol
  • ACAD
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $53.66
  • (As of Friday Closing)

ACADIA Pharmaceuticals General Information

Description

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 3611 Valley Centre Drive
  • Suite 300
  • San Diego, CA 92130
  • United States
+1 (858) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ACADIA Pharmaceuticals Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$53.66 $54.46 $30.02 - $58.72 $8.53B 159M 1M -$1.71

ACADIA Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 5,902,541 5,915,630 2,109,129 3,373,207
Revenue 419,074 339,076 223,807 124,901
EBITDA (273,865) (242,782) (246,279) (289,697)
Net Income (267,860) (235,259) (245,192) (289,403)
Total Assets 795,664 783,183 540,202 384,506
Total Debt 49,200 9,795 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

ACADIA Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ACADIA Pharmaceuticals‘s full profile, request access.

Request a free trial

ACADIA Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address
Pharmaceuticals
San Diego, CA
580 As of 2020
00000
000000&0

0000 000

ris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate vel
0000000000000
Cambridge, MA
000 As of 0000
00.000
000000000 00.000

00000000

ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolo
000000000000000
Coral Gables, FL
00 As of 0000
000.00
0000 0000-00-00
00000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ACADIA Pharmaceuticals Competitors (46)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
SAGE Therapeutics Formerly VC-backed Cambridge, MA 000 00.000 000000000 00.000
00000000 000000000 Formerly VC-backed Coral Gables, FL 00 000.00 00000000 000.00
00 0000000 Formerly Accelerator/Incubator backed Paris, France 00 000.00 000000000 000.00
000000000 00000000 Corporation Pasadena, CA 000 00.000 000000 - 000 00.000
0000000000000 0000 Formerly VC-backed Cambridge, MA 000 00000 00000000 00000
You’re viewing 5 of 46 competitors. Get the full list »

ACADIA Pharmaceuticals Executive Team (19)

Name Title Board Seat Contact Info
Stephen Davis JD Chief Executive Officer & Board Member
Elena Ridloff Chief Financial Officer, Finance & Executive Vice President
Glen Baity JD Corporate Secretary, Executive Vice President & Board Member
Michael Yang Executive Vice President & Executive
Mark Schneyer Senior Vice President, Business Development & Chief Business Officer
You’re viewing 5 of 19 executive team members. Get the full list »

ACADIA Pharmaceuticals Board Members (13)

Name Representing Role Since
Daniel Soland Self Board Member 000 0000
Edmund Harrigan MD Self Board Member 000 0000
Julian Baker Self Board Member 000 0000
Laura Brege ACADIA Pharmaceuticals Board Member 000 0000
Stephen Biggar Ph.D Self Chairman & Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

ACADIA Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ACADIA Pharmaceuticals Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 24-Aug-2020 000000000000000000 000.00 Biotechnology 0000000 00000 00
To view ACADIA Pharmaceuticals’s complete acquisitions history, request access »

ACADIA Pharmaceuticals Subsidiaries (1)

Company Name Industry Location Founded
000000 Biotechnology Dallas, TX 0000
To view ACADIA Pharmaceuticals’s complete subsidiaries history, request access »